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XL-MSWith the continuing trend to study larger and more complex systems, the application of protein
cross-linking coupled with mass spectrometry (XL-MS) provides a varied toolkit perfectly suited to
achieve these goals. By freezing the transient interactions through the formation of covalent bonds,
XL-MS provides a vital insight into both the structure and organization of proteins in a wide variety of
conditions. This review covers some of the established methods that underpin the ﬁeld alongside the
more recent developments that hold promise to further realize its potential in new directions.
 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
1.1. Mass spectrometry and protein interactions
The application of mass spectrometry to the elucidation of pro-
tein interactions has led to the development of a wide range of
methods. These include detection of non-covalent interactions in
the gas-phase [1], the identiﬁcation of protein tertiary structure
using reactive species [2,3], hydrogen–deuterium exchange [4,5]
for conformational studies, and the use of cross-linking reagents
for the elucidation of both tertiary and quaternary structure and
identifying protein–protein interactions. As these techniques all
provide different information about the system being studied, it
is further possible to then combine these technologies [6]. The
popularity of these methods has only grown with the increasing
desire to focus on larger and more complex systems which typi-
cally are not amenable to established atomic resolution studies
[7]. Further beneﬁts of these techniques are: the ability to apply
them at, or near to, physiological conditions; they require signiﬁ-
cantly less material; and they are less stringent on the purity than
NMR or X-ray diffraction.
The success of elucidating protein structure with XL-MS has led
to a large number of software solutions andmethods focused on this
application (reviewed by Sinz [8,9]; Rappsilber [10]; Sharon [11];
and protocols by Schmidt et al. [12] and Leitner et al. [13]). The over-
all workﬂow of cross-linking combined with mass spectrometry
can, however, be applied more broadly. With an understanding ofthe basic principles, novel data can often be obtained without a sig-
niﬁcant investment in developing the methodology. This review
covers this process to provide an introduction to themethods avail-
able and the challenges involved, alongside previously unpublished
data on two alternative cross-linking strategies.
1.2. Cross-linking in the elucidation of protein interactions
Some of the earliest reports of applying bi-functional reagents
to the study of protein structure focus on how they alter the phys-
ical properties of protein ﬁbers [14]. By the 1960s, the same
regents were being used to probe the membrane proteins on the
surface of cells, but the interpretation of the data was very limited
[15]. It was the combination of these reagents with other analytical
techniques, including SDS–PAGE [16] and enzymatic digestion
[17,18], during the 1970s that showed their potential to analyze
quaternary structure and protein interactions.
Today, protein cross-linking is commonly undertaken using
homo-bi-functional NHS-esters [19], which form bridges between
lysine residues that are in close proximity to each other. The range
of this interaction is often controlled by varying the length of the
space between the two functional groups. Once formed, the cova-
lent bridges between proteins provide a route to analyze otherwise
transient interactions.
1.3. In vivo cross-linking
This process of stabilizing otherwise undetectable interactions
has been successfully applied in vivo. The use of membrane
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little disruption to active protein organization. To achieve this, cells
containing the complex of interest are washed and then incubated
with the appropriate cross-linking reagent. The cross-linked reac-
tion must then be quenched and the complex of interest can be
puriﬁed by immunoprecipitation before analysis by immunoblot-
ting or similar analytical techniques to identify interacting proteins
[20–22].
1.4. Mass spectrometry in combination with protein cross-linking
As demonstrated, the elucidation of binding interactions at a
protein level continues to be a clear utility of cross-linking
reagents. This, combined with ongoing advancement in mass
spectrometry over the last decade, is still providing signiﬁcant
opportunities to develop these processes; in particular, increasing
sensitivity and accuracy while at the same time notably reducing
the acquisition time required to obtain mass spectra [23,24].
It is these advances that form the basis of many of the new
methods being developed to apply protein cross-linking to ﬁnd
novel co-factors within speciﬁc complexes [25] or even targeted
to a speciﬁc genomic locus [26,27].
1.5. Structural characterization of proteins and protein complexes
While the application of cross-linking combined with mass
spectrometry to provide protein level information continues to
be of great value, more detailed analysis is possible.
In a standard shotgun proteomic analysis, the protein sample is
digested in peptides by a speciﬁc protease, often trypsin. The pep-
tides are then separated by liquid chromatography directly inter-
faced with a mass spectrometer. In each cycle, ﬁrst a survey scan
is conducted to identify ions likely to be peptides. Typically, the
use of data-dependent acquisition would then allow for these ions
to automatically undergo some form of fragmentation to provide
sequence information. The masses and fragmentation patterns
detected by the mass spectrometer are then submitted to a data-
base search against either a general or a species speciﬁc list of
known proteins [28–31].
Identiﬁcation is established by the presence of peptides with a
sequence that maps on to the parent protein sequence. To provide
conﬁdence in the result, a reasonable cut-off is typically set for the
minimum number of unique peptides detected that correlate to aA B
D
Fig. 1. The typical analysis of a cross-linked sample by shotgun proteomics. (A) The p
Residues within the range of the cross-linking reagent are then covalently bonded and
protease to form peptides. (D) Data-dependent acquisition is used to identify peptide
identiﬁed peptides are then fragmented to provide sequence speciﬁc information.particular protein. Further conﬁdence can be gained by using a
decoy database to establish a false discovery rate at either the pep-
tide or protein level (reviewed by Choi and Nesvizhskii [32]).
It has been possible to extend and develop these methods by
including the possibility for the identiﬁcation of cross-linked pep-
tides (see Fig. 1). The characterization of these peptides provides
the opportunity to gain high-throughput structural insights of pro-
tein structure and organization [33]. The difﬁculties arise, however,
with the cross-linked peptides not being identiﬁable with standard
shotgun proteomic software as the fragmentation patterns differ
from traditional peptides. Further, each interaction will only be
represented by a small number of cross-linked peptides compared
to the number of linear peptides as the cross-linking process is
nonstoichiometric, making detection of these species difﬁcult.
Despite the promises of detailed structural data, the limited num-
ber of peptides identiﬁed has resulted in the technology not yet liv-
ing up to expectations. Furthermore, the idea of varying the length
of cross-linking reagent space length to provide a molecular ruler
has been found to give inconsistent correlation to the range of
the interaction detected. Nevertheless, the information gained
about structure of targets that have not been amenable to other
strategies can be of real beneﬁt to research.
1.6. Identiﬁcation of cross-linked peptides
Within a cross-linked proteomic sample, there are a combina-
tion of different species generated (see Fig. 2). The majority of
these will be linear peptides, but typically several cross-linking
products will also be formed. The generation of cross-linked pep-
tides can be either inter- or intra-protein, both of which can pro-
vide useful information to aid structural analysis. In our study of
the architechuture of the Pol III–Clamp–Exonuclease complex
[34], we used the identiﬁcation of intra-protein cross-links to val-
idate against the known atomic structures of each of the subunits
and to provide conﬁdence in the inter-protein cross-links charac-
terized. Alongside the formation of cross-linked peptides are the
generation of loop-links, which occur when no proteolytic site
exists between two cross-linked residues or because the prote-
olytic site is not accessible. Generally, the information provided
by these loop-link sites is less useful than that provided by inter-
or intra-protein cross-links and the choice on the cross-linking
reagent used will impact the relevance of the information. Finally
we see the production of monolinks, which are produced by theC
E
rotein or proteins are incubated with a residue speciﬁc cross-linking reagent. (B)
transient interactions are stabilized. (C) The protein is then digested by a speciﬁc
s as they elute from an HPLC directly coupled to the mass spectrometer. (E) The
OH
Cross Links
MonoLink Loop linksInter-molecularIntra-molecular
Fig. 2. Schematic diagram of the products from the proteolysis of cross-linked protein samples. Squares represent amino acids. Green squares are residues from the target
protein, orange squares are from an interactor, and blue squares represent a proteolytic cleavage site. A black line represents the cross-linking moiety.
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to produce modiﬁed peptides; depending on the cross-linking
reagent used, these can provide an insight into the location of sur-
face and solvent accessible residues.
The level of complexity within the sample is further confounded
by the wide variety of possible inter- and intra-protein cross-links
that can formwithin a protein complex. The digestion of a standard
proteomic sample typically results in a small amount of variation
in the digestion products between peptide molecules due to
so-called ‘missed cleavages’ (see Fig. 3) and the potential for
post-transnational modiﬁcation.
When building a database from a known proteome to undertake
a proteomic database search, it is typical to include two or more
missed cleavages within the search parameters. The impact of this
is not computationally intensive, yet if we apply a similar model to
the analysis of samples containing cross-linked proteins, it demon-
strates one of the major challenges in this ﬁeld. To undertake a
database search, it should include all potential cross-linked
peptides. The complexity of this task is demonstrated by trying
to model these potential products. It should be apparent that every
residue containing a side chain that is reactive to the cross-linking
reagent can potentially form a covalent bond to every other reac-
tive amino acid side chain if we have no prior knowledge of the
structure. This alters the search space from being a linear problem
(e.g. n proteins = k  n peptides) to an algorithm that scales much
more poorly as n proteins gives rise to a solution essentially pro-
portional to n2 cross-linked peptides [35]. This means the inclusionD
1 Missed Clevage Site
2 Missed Clevage Sites
A
B
C
D
Fig. 3. Schematic representation of a protein undergoing proteolysis and illustrating th
length protein before enzymatic digestion. The simplest solution is a protease that will cl
shown in blue. In the case of trypsin, these would be any lysine or arginine residues th
analysis of the products shows the presence of partial proteolysis products; these are the
as for a single missed cleavage there are two series of these peptides. One originates sequ
second is generated in the same manner from the second cleavage site. A similar meth
generating three series of potential products.of complicating factors like missed-cleavages or post-translational
modiﬁcations results in a substantial increase in the number of
potential cross-linked products. The issue of complexity is further
exacerbated as most common cross-linking reagents react speciﬁ-
cally with the basic side chain of lysine residues. The process of
cross-linking therefore actively blocks the digestion of trypsin at
these sites.
These challenges are not insurmountable, but it has led to the
development of many novel strategies and methods. These take
the form of three main strategies: to enrich for the peptides of
interest over linear peptides; to develop new cross-linking
reagents; and for both methods and technologies to aid in the
detection of the cross-linked peptides from complex mixtures.
2. Methods
2.1. Peptide-based enrichment
2.1.1. Variation of proteolytic enzyme
Trypsin is used almost ubiquitously in proteomics [36] due to
its high speciﬁcity and the convenience of the peptides it gener-
ates. As the majority of tryptic peptides contain either an arginine
or lysine at the C-terminus, this aids peptide ionization efﬁciency
and detection of product ions. The disadvantage of this is the
majority of cross-linking reagents are lysine reactive and therefore
reduce digestion efﬁciency. To address this, an evaluation of alter-
native proteases—including Lys-C, Lys-N, Glu-C and Aps-N—onigest
e complexity of products arising from ‘missed cleavage sites’. (A) Illustrates a full-
eave at all points in the protein sequence that match the speciﬁcity of the enzyme –
at are not followed by a proline residue (B). In the majority of samples, however,
result of ‘missed cleavages’ (C). Care has to be taken when modeling these peptides,
entially from the start of the protein from cutting at alternate cleavage sites, and the
od is used to generate peptides from the result of two missed cleavage sites (D),
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taken by Leitner et al. [37]. The work showed that a signiﬁcant
increase in the number of cross-links could be detected by chang-
ing the enzyme used in sample preparation.
2.1.2. Size exclusion chromatography
A second part of the study by Leitner et al. [37] investigated the
application of size exclusion chromatography to aid the puriﬁca-
tion of cross-link peptides within samples. Analysis of the eluted
peptides showed that the cross-linked peptides could be detected
at higher concentrations in the earlier fractions and therefore size
exclusion chromatography promoted their enrichment over modi-
ﬁed or unmodiﬁed peptides. For tryptic digests, this led to an
increase from 44 to 150 detectable cross-linked peptides when
the processed and unprocessed samples were compared.
2.1.3. Strong cation exchange
An alternative to the use of size exclusion has been the develop-
ment and optimization of strong cation exchange (SCX) based
enrichment strategies [7,38]. Unlike size exclusion chromatogra-
phy, the fractionated products of the process contain high salt con-
tent and it is necessary to undertake further puriﬁcation before
analysis by mass spectrometry, although some of this can be mit-
igated by the use of volatile salts. The process relies on the
cross-linked peptides having four terminal residues compared to
only two on a linear peptide, but this also limits the choice of pro-
tease as SCX is most effective when protonation sites are available
at both the N- and C-termini. To avoid this limitation, we made use
of successive enzymatic digests, initially a tryptic digest before
enrichment of the cross-linked peptides followed by a second
digest with Glu-C. Using this combination resulted in approxi-
mately 1.5-fold enrichment in the number of cross-linked peptides
identiﬁed over trypsin alone. The exact ﬁgure was dependant on
the sample analyzed [34]. An alternative to the use of SCX is the
application of only selecting those ions with a charge >3+ for frag-
mentation. While this does not reduce the complexity of the sam-
ple, it has proved successful in increasing the number of
cross-linked peptides detected as less time is spent on the acquisi-
tion of lower charged species which have a higher representation
of linear peptides.
The modiﬁcation of the amino acid side chains on reaction with
cross-linking reagents is typically associated with an inability for
enzymatic cleavage at this location. Trypsin, for example, is unable
to carry out proteolysis after the amine of the lysine has been con-
verted into an amide by bi-functional activited esters. This feature
of cross-linked peptides makes it possible to use a non-speciﬁc
digestion to enrich these peptides [39]. In a typical sample prepa-
ration, the addition of Proteinase K to a solution of cross-linked
proteins will result in the complete digestion of the
un-cross-linked regions of the sample. The disadvantage of this
and related methods is that, as while this greatly aids the identiﬁ-
cation of cross-links against the background, the task of predicting
cross-linked peptides sequences is greatly complicated by the lack
of protease speciﬁcity. The implications of this will be discussed in
more detail in Section 2.4.
2.2. Cross-linking reagents
The growth in the use of protein cross-linking coupled with
mass spectrometry has led to an expansion in the number of
cross-linking reagents in the literature with a variety of chemical
speciﬁcity and distance between functional groups [40–46].
These have been designed to solve many of the different limita-
tions that more traditional reagents have faced or to provide some
kind of previously unmet utility. The diversity of the reagents now
available is much larger than previously but there are still manylimitations that continue to be the focus for development. The
recent key developments lie in the types of chemistry available
to undertake the cross-linking reaction and the novel designs that
aid in the detection of the cross-linked peptides formed by the use
of these reagents.
2.2.1. N-hydroxysuccinimide (NHS) activated ester
The use of N-hydroxysuccinimide (NHS) activated ester
cross-linking reagents (see Fig. 4) continues to be a stable basis
for a large number of cross-linking studies [47–50,34,51]. This is
likely due to their commercial availability and the development
of stable isotope labeled reagents to aid detection (see
Section 2.4) [41]. NHS esters are primarily used for their ability
to target the primary amines found in the side chain of lysine resi-
dues. The reactivity is aided by the position of the amine at the end
of the side chain, reducing steric hindrance, while the polar nature
of the residue means it is typically found on the surface of proteins
or at interface sites. Typically NHS esters have been assumed to be
speciﬁc in their reactivity, only targeting lysine residues, but there
is increasing evidence that these reagents show a much broader
range of targets with amino acids that have previously been
ignored [52]. In a standard cross-linking reaction, the amount of
the NHS ester and time for which it is incubated with the protein
sample has to be optimized on an experiment-by-experiment basis
as it varies with the lysine content and availability within the sam-
ple. To control the end point of the reaction, it is typically
quenched with an amine containing buffer before the products
are monitored by electrophoresis. Care must be taken to identify
and control the formation of higher-order oligmers as these may
lead to the detection of non-speciﬁc cross-linking products. If it
is not possible to optimize conditions to avoid the formation of
these products, it may be possible to remove them before analysis
by additional puriﬁcation using size exclusion chromatography
under denaturing conditions [34].
A major drawback of these reagents is their ability to inhibit
proteolysis by trypsin at the reaction site, resulting in larger pep-
tides under these conditions. In proteins with a limited number
of potential proteolysis sites, this is particularly problematic. This
can be resolved by the use of alternative enzymes or a combination
of enzymes during sample preparation (see Section 2.1.1).
2.2.2. Acid speciﬁc cross-linking reagents
The prevalence of reagents that focus on the coupling of lysine
residues in mass spectrometry-coupled cross-linking experiments
has resulted in increasing efforts to develop alternative linkers that
target different residues [53]. The most signiﬁcant recent develop-
ment in cross-linking chemistry was the demonstration of two acid
residue speciﬁc cross-linking reagents – adipic acid dihydrazide
and pimelic acid dihydrazide (see Fig. 4) – which provide a promis-
ing addition to the toolkit of lysine (and cysteine) speciﬁc reagents
that are currently available by overcoming the previous require-
ment of relatively low pH [54]. They also present an interesting
potential starting point for the development of gas-phase cleavable
versions (see Section 2.2.5) based on the same chemistry.
2.2.3. Arginine speciﬁc cross-linking reagents and protein–DNA
interactions
An untapped potential of protein cross-linking reactions is the
possibility of developing a mechanism for identifying protein–
DNA or protein–RNA interactions. The use of diglyoxal compounds
to investigate these interactions has been demonstrated in the
analysis of the organization of the ribosome [55,56]. The applica-
tion of these cross-linking reagents has been demonstrated for
both the study of protein structure with the identiﬁcation of argi-
nine–arginine cross-links [57,58] in proteins and its use in the
analysis of nucleic acid structure [59]. To aid the identiﬁcation of
Fig. 4. Examples of the different cross-linking reagents discussed in this review. Disuccinimidyl suberate (DSS) is a lysine reactive cross-linking reagent, shown here in its
deuterated form (see Section 2.4.2). Biphenyldiglyoxal is an arginine reactive cross-linking reagent, shown here with a carbon-13 label (see Section 2.2.3). CBDPS
(Cyanurbiotindimercaptopropionylsuccinimide), brings together multiple different features to aid detection of cross-linked peptides by mass spectrometry (see
Section 2.3.1). Adipic and pimelic acid dihydrazide are acid reactive cross-linking reagents; they are shown here as a pair to illustrate how cross-linking length can be
varied (see Section 2.2.2). p-Benzoyl-L-phenylalanine is an example of a cross-linking reagent that can be genetically encoded into the protein (see Section 2.2.4).
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biphenyldiglyoxal (see Fig. 4), from the Friedel–Crafts acylation
reaction between biphenyl and 13C2-acetyl chloride followed by
oxidation of the terminal carbons using HBr/DMSO oxidation.
Initial evaluation of diglyoxal-based cross-linkers for the identiﬁ-
cation of protein–protein interactions was conﬁrmed by the
incubation of the puriﬁed cross-linker with the target PyrR protein
complex [60]. The range of molar ratios between the cross-linking
reagentto protein were varied from 5:1 to 50:1 in 50 mM ammo-
nium borate buffer pH 8.1. Monitoring the reaction by SDS–PAGE
showed the clear formation of a cross-linked homotetramer in
the case of PyrR. Using this reagent, it was possible to identify
the formation of arginine-selective cross-links (see Fig. 5) in the
human PyR complex [61,62] where previous attempts with NHS
esters had been unsuccessful.
2.2.4. Genetically encoded cross-linking reagents
The development of genetically encoded p-benzoyl
-L-phenylalanine (pBpa) [64] (see Fig. 4) using the amber codon
(UAG) allows for the incorporation of a photo-activated
cross-linking reagent into a speciﬁc gene within an organism.
The ability to genetically encode a photo-reactive amino acid has
several distinct advantages for the investigation of protein interac-
tions and binding within the cell. The location of the amino acid
can be used to directly probe where on the surface individual inter-
actions happen. This is achieved by generating a series of mutants
with the pBpa incorporated at different points along the amino
acid sequence. Only when the activated amino acid can be
cross-linked on the surface of the protein and in contact with a sec-
ond species will that interaction be detected. By studying the
results of these in turn, we can then identify the environment sur-
rounding the protein. This method greatly reduces the complexity
of the problem in identifying the peptides, by limiting the
cross-links to only one possible position from the mutant protein,
therefore the identiﬁcation of the proteolytic product by mass
spectrometry is not signiﬁcantly more difﬁcult than a typical linearpeptide search. The application of this method has been aided by
the development of an isotope labeled form of the amino acids
[65], meaning that only the cross-linked peptides and the peptides
within the site of incorporation will contain the isotope label (see
Fig. 6).
These beneﬁts were utilized in the development of Hekate’s [63]
‘amber codonmode’. Once enabled, the softwarewill request details
of known peptides containing the amber codon residue alongside
information on the type of isotope label used and the mass of the
amber codon residue both before and after cross-linking (available
from http://github.com/MRC-LMB-MassSpec/Hekate at publica-
tion). The peptide containing the amber codon can be predicted
from the amino acid sequence of the bait protein and the speciﬁcity
of the protease used. Using this method, it was possible to identify
the site of cross-linking between Sdo1 – a yeast authologue of
SBDS, a protein implicated in Shwachman–Bodian–Diamond syn-
drome – and Eﬂ1 (see Fig. 7).
2.2.5. Cleavable cross-linking reagents
A variety of cleavable cross-linking reagents have been devel-
oped to aid identiﬁcation and sequencing of cross-linked peptides.
Some of the oldest forms of these reagents make use of a reducible
di-sulﬁde bridge within the molecule [42]. The protein is
cross-linked in the usual way to stabilize non-covalent interactions
and then digested; and the sample is then analyzed by mass spec-
trometry. The convenience of this method, though, is that
cross-linked peptides can be re-analyzed following reduction with
a thiol compound. The products of this reaction still have a detect-
able modiﬁcation, but now appear as linear peptides.
Using differential peptide mapping (comparing the sample
spectra before and after reduction and identifying peaks that are
different between conditions), it is possible to characterize the
products of cross-linking. Cross-linked peptides often fragment
poorly and the spectra are much more difﬁcult to analyze than that
of a linear peptide. Difﬁculties arise as the two peptides chains
fragment independently often with one dominating, e.g. from the
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Fig. 5. (Top) Product ion spectra of the RDDLTVKTDDHEPL monolinked peptide, conﬁrming the incorporation of the BPG monolink. (Bottom) Product ion spectra of the
detected cross-linked peptide. The precursor ion ELPIRADYIGKNIPTSK-VILVDDVLYTGRTVR was detected with a mass accuracy of 0.6 ppm. These peptides were identiﬁed
using Hekate [63].
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second peptide sequence. The beneﬁt of the use of differential pep-
tides analysis, therefore, is that it allows for the resultant linear
peptides to be fragmented with greater ease when compared to
that of the precursor cross-linked peptide. Cross-linking reagents
that cleave under UV-light also exist and provide a similar utility
[66].
A more recent application of cleavable cross-linkers is the
development of cross-linking reagents that can be cleaved within
the mass spectrometer [67]. These cross-linking reagents are frag-
mented into two separate peptide chains by collision-induced dis-
sociation (CID) within the mass spectrometer. The linear peptide
products produced in the gas phase can then be selected and iso-
lated before a second round of fragmentation. This fragmentationthen provides information on the amino acid sequence for each
constituent linear peptide. This process is a compromise: the spec-
tra produced are more easily assigned, but it results in a loss in sig-
nal intensity and increased acquisition time. The data-dependent
acquisition techniques needed to undertake this kind of experi-
ment are common to a range of mass spectrometers. These frag-
mentation patterns are then suitable for identiﬁcation by the use
of standard database solutions found in proteomic software.
2.3. Cross-linking reagents and sample enrichment
As already described, the use of chromatography to enrich for
cross-linked peptides (see Sections 2.1.2 and 2.1.3) has been shown
to be effective, but due to the similarities of the linear and
Fig. 6. The analysis of protein interactions using genetically encoded cross-linking reagents uses many of the same steps as a standard cross-linking strategy (see Fig. 1). The
signiﬁcant difference is the cross-link will only be initiated from the position where the photo-reactive amino acid (pBpa) has been included. This reduces the complexity of
the ﬁnal analysis.
Fig. 7. The product ion spectrum of the isolated peptide as identiﬁed by Hekate and generated by the use of an amber codon mutant to incorporate pBpa into a bait protein
(Sdo1). Amino acid u = pBpa.
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separate one from the other. The problem is further complicated
as the linear peptides are very much in excess of the target
cross-linked peptides. The development of afﬁnity-based puriﬁca-
tion with the potential to exclusively enrich for peptides contain-
ing the cross-linking reagent have the potential to provide
dramatic beneﬁts to the study of protein structure.
2.3.1. Biotin labeled cross-linking reagents
The development of PIR [40] and CBDPS [68] (see Fig. 4)
cross-linking reagents brought together several different strategies
into a single reagent. In particular the inclusion of a biotin tag, as
previously demonstrated by Alley et al. [69], within the bridge of
the cross-linking reagent allows for the cross-linked peptides to
be puriﬁed with a much higher speciﬁcity than is possible by other
techniques. This tag is combined with the inclusion of three sites
that can be simultaneously cleaved within the gas-phase bylow-energy collision induced dissociation. This releases a reporter
ion, and the separated chains of the cross-linked peptides for
sequencing. A convenient result of this is that linear peptides,
loop-link peptides and cross-linked peptides will give very differ-
ent products as a result of this ﬁrst fragmentation step, while the
reporter ion aids in providing a key marker for informatics soft-
ware to identify relevant spectra. The product ions that represent
the individual peptides chains can undergo another round of frag-
mentation to provide sequence information, as previously dis-
cussed in Section 2.2.5.
2.3.2. Click-based afﬁnity tags
An alternative to the incorporation of a biotin tag has been
demonstrated by the incorporation of an azide functional group
within the linking reagent [44]. The inclusion of an azide is conve-
nient as it is both much smaller than a biotin tag and enables for
the use of a wide range of ‘click chemistry’ to capture the
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reactive cyclooctyne resin (ARCO-resin) was used to enrich for
cross-linked peptides. The resin can then be washed to remove
any non-speciﬁc binding from linear peptides or other contami-
nants. The cross-linked peptides can then be released from the
resin by the reduction of a disulﬁde bond in the linker bound to
the resin [70].
2.4. Detection
2.4.1. Software
There has been a long history in the use of peptide databases to
analyze proteomic data [28]. It was therefore inevitable that
attempts would be made to adapt these techniques to the develop-
ment of software packages to provide the same functionality for
the analysis for cross-linked proteome data.
Cross-linked peptides pose a unique set of problems to the
application of database searches. The size of the problem (see
Section 2) is signiﬁcantly larger and scales much more poorly than
that for linear peptides. The peptides fragment in a different man-
ner to linear peptides and the number of peptides that represent a
particular interaction are non-stoichiometric, thus reducing the
statistical power of any result from a cross-linking experiment.
The development of reagents with multiple MS-directed features
– for example PIR [40] and CBDPS [68] reagents (see
Section 2.3.1) include reporter ions and isotope labels – provide
potential improvements in detection. The impact of this wide vari-
ety of cross-linking methods means that the more complex
cross-linking reagents need quite speciﬁc software e.g. BLinks
and the identiﬁcation of PIRs [71] or DXMSMS [72] for the analysis
of isotope labeled CID cleavable cross-linked products.
Several attempts have been made to simplify the identiﬁcation
of the cross-linked peptides including fast-sorting [35], xQuest’s
[73] ‘ion-tag’ method and my own Hekate [63], which makes use
of indexed databases.
The ‘ion-tag’ method employed by xQuest searches each spectra
against a database of linear peptides in a precursor mass indepen-
dent manner. The results of this initial search then identify which
potential linear peptides can be combined to form potential
cross-linked peptides. This greatly reduces the complexity of the
initial database needed to search the cross-linked proteomic data.
In the development of Hekate [63], a different approach was
taken. Hekate interfaces to a SQL database by the use of the Perl
DBI modules. The database employed provides several indexing
methods to aid the rapid searching of data. Futhermore, many
databases have already been developed with a signiﬁcant focus
on speed and large data sets, thus making them potentially suitable
for the exhaustive search of all potential cross-linked peptides.
Conveniently, the DBI in Perl provides a uniﬁed interface to facili-
tate changes in the database used. During the initial stages of
development, SQLite was used for convenience; switching from
SQLite to MySQL resulted in a reduction of 26% in the time to rean-
alyze the data from the original publication [63] with no further
optimization. While it has not yet been realized, this demonstrates
the potential of undertaking this on much larger datasets by the
application of the appropriate database choice and supporting
hardware. Moreover, the use of a client/server based database such
as MySQL opens up the possibility of using high-performance clus-
ters in the analysis of data.
2.4.2. Isotope labeling
Identiﬁcation of cross-linked peptides computationally by the
scoring of each individual spectra is time consuming and wasteful
of computer resources when we consider that, without highly
speciﬁc enrichment, the majority of species detected will reﬂect
the linear peptides. Therefore, techniques that aid in the detectionof cross-linked peptides from the precursor ion mass are particu-
larly valuable.
A convenient method to achieve this result is the use of
oyxgen-18 labeling [74]. The proteolytic digestion of a sample is
undertaken in oxygen-18-enriched buffer (H218O) with trypsin will
incorporate two oxygen-18 atoms in the C-terminus of the pep-
tides. As cross-linked peptides have two C-termini, this results in
the inclusion of four oxygen-18 atoms. The cross-linked peptides
can then be identiﬁed either by a characteristic mass shift or by
the 1:1 mixture of labeled and unlabeled samples. This results in
characteristic doublets in the spectra with an 8 Da spacing,
whereas linear peptides will only show a 4 Da doublet. The beneﬁts
of this method are that it is fast and can easily be adapted to a wide
variety of cross-linking reagents. Software packages can then be
designed to recognize these doublets and therefore quickly identify
linear and cross-linked ions from the precursor spectra.
Data-dependent acquisition also provides the opportunity to selec-
tively target only those ions that show an appropriate doublet for
fragmentation, potentially providing the opportunity to acquire
less linear peptide data and more data speciﬁc to protein interac-
tions. One issue that can complicate the analysis is incomplete
incorporation of two oxygen-18 atoms into each carboxylate of
the C-terminus. This can occur since the product is required to
rebind to the protease in order to facilitate the incorporation of
the second oxygen-18 atom.
A popular alternative strategy to the addition of oxygen-18
labels during proteolytic digestion is the application of isotope
labeled cross-linking reagents [41,75]. By synthesizing two ver-
sions of a cross-linker, one with and one without the incorporation
of a stable isotope, it is possible to use the two in a known ratio to
provide a doublet on analysis by mass spectrometry. Unlike
oxygen-18 labeling, the use of an isotope label within the
cross-linker also aids the detection of monolinks and loop-links,
not just cross-linked peptides with two C-termini. This may or
may not be of beneﬁt depending on the research undertaken. The
placement of the label within the cross-linking regent also pro-
vides the opportunity to use a wider variety of stable isotopes to
label samples. In particular, the use of deuterium as a stable iso-
tope label has been used in a wide range of studies due to the com-
mercial availability of bi-functional NHS-activated esters
[7,19,34,51,76,73,75,77]. While it has previously been noted that
deuterium labeling can cause a detectable difference in retention
time when separating peptides by reversed-phase liquid chro-
matography because of the chromatographic isotope effect [78],
this has not been reported to have had a signiﬁcant impact when
identifying cross-linked peptides by this method.
The formation of a ‘mass doublet’ by the use of isotopic labels
has been a particularly valuable development as it provides a
visual cue for the identiﬁcation of cross-linked peptides, a trigger
for data-dependent acquisition, and a ﬁlter for the analysis that
is easily automated in software. The convenience of this method
has led to the wide variety of software written to undertake the
analysis of cross-linked protein data applying these methods, sup-
porting some form of isotope labeling in an initial ﬁltering of the
data before scoring. This results in both faster processing of data
produced by protein cross-linking and higher conﬁdence in the
identiﬁcation of cross-links due to both the labeled and unlabeled
peptide spectra providing complementary information. Both
xQuest and Hekate use the shift of peptide fragments between
the heavy and light forms of cross-linked peptides to identify when
a particular fragment contains the cross-link and to reduce the
complexity of the spectra. As cross-links are often low in abun-
dance, this cross-validation approach is helpful for hard-to-assign
fragmentation spectra.
The success of stable isotope labeling in XL-MS has led to the
prevalence of one-to-one ratios in experimentation as these result
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though, it has been shown that this does not result in the highest
number of identiﬁed peptides [79]. In an analysis by Fischer
et al., they undertook the comparison of a 1:1, a 1:2 and a 1:4 ratio
between the two forms of the cross-linker. The results demon-
strated that the highest number of cross-linked peptides were
identiﬁed with a ratio of 1:4. This is presumably because it pro-
vided the highest intensity signal in terms of the ‘light’ peptides,
thus aiding identiﬁcation. How dependent this result was on the
computational methods they employed, however, is not clear.
2.5. False discovery rates (FDR)
The challenge in gaining reliable insight from the digestion of
cross-linked protein samples is not just one of identiﬁcation.
Once a potential cross-linked peptide has been detected and its
sequence has been established, the next step is validation of the
result. This will typically be achieved by undertaking further
research using a complementary technique, but if we are to use
XL-MS on large and complex systems then this may be impractical.
The application of target-decoy strategies as implemented by
xProphet [80] (alongside xQuest), Plink [81] and later Hekate allow
for the provision of false discovery rates (FDR). To calculate the
FDR, two databases of peptides are generated: the target database
of known sequences, and a second decoy database. The detected
peptides are then scored against potential matches in both data-
bases (and sometimes a hybrid database containing cross-links).
The FDR is established by counting the number of spectra that
matched the decoy database with a score equal to or greater than
the spectra of interest. This is then expressed as a percentage of the
total number of spectra that matched either database at that score
or above. In a typical study, any result with an FDR <1% is consid-
ered of interest. The addition of false discovery rates to the analysis
of cross-linking methods is a vital tool for the comparision of sam-
ples and for the quantitative measurement of the quality of data
produced.
2.6. Quantitative cross-linking
Historically, the use of stable isotopes was undertaken to aid in
the identiﬁcation of cross-linked peptides (see Section 2.4.2); how-
ever, it has recently been demonstrated that the same stable iso-
tope cross-linking reagents can be used to provide relative
quantiﬁcation of interactions between samples. If the two protein
samples in different conditions are reacted separately, the process
can be used to label the cross-linked products depending on the
conditions in which they were generated [79]. Comparison of the
abundance of cross-linked peptides provides quantitative informa-
tion on the organization of the protein population. Because of the
immaturity of the technique, there is currently only a limited
amount of support in terms of software for the application of this
method; however, the provision of XiQ [79] with the original pub-
lication provides a minimal framework to further establish and
apply the technique [12]. This limited integration of support in
cross-linking currently means that quantiﬁcation is undertaken
manually [12].3. Conclusions
Mass spectrometry coupled with protein cross-linking has and
continues to demonstrate considerable value in the characteriza-
tion of the interactions between proteins. Even the most basic
application to the stabilization of transient interactions within pro-
tein complexes becomes immensely powerful when applied to the
investigation of novel binding partners that would otherwise notbe detected. At the same time, some parts of the ﬁeld are develop-
ing at a rapid pace.
The wide range of applications of XL-MS continues to grow. The
rise of systems biology has led to a fundamental need to analyze
more complex systems more rapidly. Even relatively immature
methods have had a large impact on what is achievable in the ﬁeld.
This advancement is demonstrated by the application of quantita-
tive cross-linking: despite there being no integrated solutions cur-
rently available, their application to the analysis of the
organization of an F-type ATPase has provided insight into a highly
complex problem [82]. As more integrated methods for the analy-
sis of these data are developed, we can expect further application
and scope of XL-MS to the analysis of these systems.
The availability of methods [73,83] to undertake the large-scale
analysis of cross-linked peptides from complex mixtures has been
a major development for the ﬁeld. This has led to the ability to
build protein interaction networks [84] from in vivo cross-linking
experiments. The value of these techniques is demonstrated by
the current efforts already committed to build a proteome scale
static map of interactome using Y2H assays [85,86] and the analy-
sis of sequence co-evolution [87]. XL-MS could achieve the same
results in a context speciﬁc manner providing an in vivo insight
that builds upon the current static interactome data to include
dynamic information of how interactions between proteins change
in response to a speciﬁc stimuli or perturbation. There is no doubt
that the biggest challenges for this kind of study is expanding the
data set from around 4300 proteins within Escherichia coli pro-
teome to nearly 90,000 within the human proteome [35]. Despite
this, high performance computing remains an untapped possibility
for this research ﬁeld and, if successfully applied, has the potential
to revolutionize the way we analyze protein networks and protein
complex organization to provide a novel systems approach to
structural biology.
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